Natural Health Trends Corp.

NHTC

Consumer Cyclical Internet Retail

Natural Health Trends Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.8 million, down 7.42% from fiscal 2024.

Revenue
−20.2%
EPS
+32.5%
Free cash flow
−1,670.0%

Quarter to September 2026, against a year earlier

0.75 0.02 +2.74%
Market cap
$6.2M
P/E
n/m
Fwd P/E
75.1×
Dividend yield
53.3%
F-score
3/9
ROIC
0.00%
Net debt / EBITDA
17.0×
Dividend safety
20/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
3 4 5 3 6 7 3 4 6 6
P/E ratio
0.00 86.36 131.11 103.23 71.84 59.86 0.00 6.75 7.54 5.03
P/S ratio
0.89 1.23 1.54 0.81 1.24 0.85 0.75 1.09 0.90 0.97
Altman Z-Score
1.61 2.10 2.43 1.97 2.65 2.43 2.29 4.97 4.83 7.01
P/FCF ratio
0.00 0.00 0.00 0.00 94.15 31.62 0.00 7.09 6.77 5.32
Altman Z″-Score (non-manufacturers)
1.73 3.40 4.79 5.76 6.30 6.99 6.40 8.19 8.61 8.81
P/Operating CF
(37.04) 602.02 (977.86) 42.64 47.35 15.50 531.69 46.99 15.81 16.48
Dividend Safety Score
20 — — — — — — — — —
P/B ratio
1.52 1.61 1.62 0.80 1.25 0.78 0.78 2.33 1.97 3.38
Price to Tangible BV
1.64 1.70 1.69 0.83 1.29 0.80 0.80 2.37 2.00 3.45
EV/Sales
0.17 0.21 0.26 (0.60) (0.16) (0.64) (0.48) 0.40 0.22 0.53
EV/EBITDA
0.00 0.00 0.00 449.59 0.00 0.00 7.71 2.24 0.98 2.36
EV/Operating CF
(1.11) (2.68) (2.64) 6.12 (9.22) (20.92) 2.01 2.57 1.61 2.87
EV/FCF
(1.10) (2.64) (2.61) 5.94 (11.84) (23.55) 1.99 2.59 1.63 2.92
Quick Ratio
2.11 2.11 2.81 3.41 3.40 4.29 3.65 3.08 3.23 2.20
Current Ratio
2.50 2.45 3.21 3.79 3.79 4.64 4.12 3.49 3.61 2.47
Net Debt/EBITDA
16.99 37.62 37.28 1,055.56 (44.84) (85.60) 19.71 (3.88) (3.10) (1.95)
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.85 0.69 0.58 0.54 0.59 0.55 0.56 1.21 1.28 2.11
Operating CF/Net income
6.80 (5.89) (7.53) (15.50) 0.94 2.24 3.32 0.96 1.13 0.97
Capex/Depreciation
(0.62) (0.44) (0.28) (0.70) (0.75) (0.51) (0.09) (0.50) (0.52) (2.30)
ROE
(3.13%) 1.54% 1.24% 0.57% 1.71% 1.18% (6.80%) 34.39% 27.25% 79.12%
ROA
(1.88%) 0.92% 0.75% 0.35% 1.06% 0.75% (4.06%) 19.55% 15.33% 40.47%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(4.27%) 1.88% 1.28% 0.54% 1.57% 1.07% (6.78%) 28.73% 21.34% 64.44%
Average Days of Receivables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
37.11% 36.11% 36.44% 32.56% 29.74% 29.33% 35.07% 16.31% 16.31% 15.03%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01
Share Based Compensation of Revenue
0.33% 0.34% 0.37% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.04%
Graham Net Nets
0.54 0.54 0.54 1.12 0.73 1.16 1.11 0.39 0.46 0.27
Graham Number
0.00 1.86 1.92 1.84 3.38 3.45 0.00 22.14 19.51 28.14
Earnings Yield
(2.55%) 1.16% 0.76% 0.97% 1.39% 1.67% (9.67%) 14.82% 13.27% 19.88%
Free Cash Flow Yield
(17.07%) (6.46%) (6.41%) (12.49%) 1.06% 3.16% (32.19%) 14.11% 14.78% 18.78%
Revenue per Share
3.46 3.75 3.84 4.32 5.45 5.84 7.14 16.98 17.56 25.28
Operating CF per Share
(0.52) (0.29) (0.37) (0.43) 0.09 0.18 (1.71) 2.63 2.36 4.67
Capex per Share
(0.01) 0.00 0.00 (0.01) (0.02) (0.02) (0.02) (0.02) (0.02) (0.08)
Free Cash Flow per Share
(0.53) (0.30) (0.38) (0.44) 0.07 0.16 (1.73) 2.61 2.34 4.59
Cash per Share
2.51 3.83 4.91 6.13 7.61 8.69 8.83 11.74 12.03 11.06
Shareholders Equity per Share
2.04 2.87 3.64 4.41 5.40 6.37 6.91 7.95 8.05 7.24
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
2.04 2.87 3.64 4.41 5.40 6.37 6.91 7.95 8.05 7.24
Free Cash Flow
(6.06) (3.42) (4.32) (4.99) 0.79 1.67 (18.83) 29.50 26.33 52.27
Working Capital
20.51 30.18 44.25 57.11 68.81 78.24 82.07 107.10 109.32 84.09
Capital Expenditures
(0.07) (0.06) (0.05) (0.14) (0.22) (0.21) (0.19) (0.21) (0.28) (0.90)
Net Current Asset Value
19.20 28.50 36.74 44.89 54.60 61.50 64.94 82.13 82.31 75.63
EV/EBIT
0.00 0.00 0.00 109.90 0.00 0.00 5.35 2.26 0.99 2.38
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00 47.41 79.13 0.00 6.20 4.14 4.34
Other line items
Depreciation/Fixed assets
0.71 0.69 0.62 0.52 0.65 0.76 2.93 0.45 0.47 0.28
Cash ROIC
(11.60%) (4.46%) (4.42%) (4.17%) 0.55% 1.05% (11.00%) 13.26% 11.65% 25.09%
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
14.51 11.86 12.42 16.12 22.39 26.97 17.40 23.28 19.84 21.93
Inventory Turnover
3.96 2.96 2.53 2.59 3.32 3.34 2.17 3.83 3.93 5.06
Average Days of Payables
19.25 29.22 32.34 23.35 18.51 12.46 12.35 15.12 16.54 14.26
Days of Inventory on Hand
71.00 106.84 140.22 130.45 127.84 81.19 116.27 112.79 79.32 74.84
Average Payables
0.73 0.94 0.90 0.79 0.67 0.63 1.16 1.69 1.95 2.50
Average Inventory
2.66 3.78 4.41 4.89 4.52 5.09 9.28 10.28 9.83 10.86
Average Assets
46.89 62.23 75.95 90.59 102.15 112.22 138.21 158.74 153.80 136.10
Average Common Equity
28.15 37.24 45.88 54.82 63.59 71.38 82.46 90.24 86.53 69.62

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026